A detailed history of Bank Of Montreal transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Bank Of Montreal holds 45,045 shares of BEAM stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,045
Previous 151,066 70.18%
Holding current value
$1.13 Million
Previous $3.54 Million 68.83%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$22.57 - $33.14 $2.39 Million - $3.51 Million
-106,021 Reduced 70.18%
45,045 $1.1 Million
Q2 2024

Aug 14, 2024

BUY
$21.22 - $32.66 $3.21 Million - $4.93 Million
151,066 New
151,066 $3.54 Million
Q1 2022

May 12, 2022

SELL
$53.73 - $82.16 $162,264 - $248,123
-3,020 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$68.02 - $99.06 $205,420 - $299,161
3,020 New
3,020 $254,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.76B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.